Becoming a life sciences superpower

September 1, 2021

This report advocates for increased,
long-term public investment in research
and innovation, particularly in the life
sciences sector, to accelerate the UK on
its trajectory as a global leader in the field.
This report sets out recommendations ahead
of the Comprehensive Spending Review
for policymakers to support innovative
businesses, achieve the Prime Minister’s aim
of becoming a life sciences superpower, and
ultimately, deliver health benefits for Britain –
and the world – for generations to come.

Spotlight

Biomere (Biomedical Research Models, Inc.)

Established in 1996, Biomere is dedicated to working in collaboration with our customers to advance life science research in multi-species. Biomere is differentiated by our quality of work, flexibility, adaptability and speed.

OTHER WHITEPAPERS

HFPP Fraud, Waste, and Abuse in the Context of COVID-19

whitePaper | January 24, 2022

Since early 2020, coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome.

BIOTECHNOLOGY INNOVATION ORGANIZATION

whitePaper | January 4, 2022

The Biotechnology Innovation Organization (BIO) appreciates the opportunity to participate in the 2022 Special 301 Review: Identification of Countries under Section 182 of the Trade Act of 1974: Request for Public Comment and Announcement of Public Hearing.